AIM ImmunoTech reports progress in pancreatic cancer drug trial

Go back to AIM ImmunoTech reports progress in pancreatic cancer drug trial
Aerosonic Corp. (NYSE: AIM) Delayed: 0.36 -0.02 (5.26%)
Previous Close $0.38    52 Week High $8.92 
Open $0.37    52 Week Low $2.64 
Day High $0.37    P/E 0.58 
Day Low $0.35    EPS $0.62 
Volume 928,387